Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sara J Khosrowjerdi, M.D.

Concepts (31)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Sara Khosrowjerdi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sara Khosrowjerdi has written about over time.
Carcinoma, Squamous Cell, 1 publications between 2019 and 2019, average publication date September 2019. Carcinoma, Non-Small-Cell Lung, 2 publications between 2019 and 2019, average publication date November 2019. Phospholipase D, 1 publications between 2019 and 2019, average publication date December 2019. Lung Neoplasms, 3 publications between 2019 and 2021, average publication date July 2020. Diazepam, 1 publications between 2020 and 2020, average publication date October 2020. Heart Block, 1 publications between 2020 and 2020, average publication date October 2020. Hydroxychloroquine, 1 publications between 2020 and 2020, average publication date October 2020. Hypnotics and Sedatives, 1 publications between 2020 and 2020, average publication date October 2020. Long QT Syndrome, 1 publications between 2020 and 2020, average publication date October 2020. Poisoning, 1 publications between 2020 and 2020, average publication date October 2020. Saline Solution, Hypertonic, 1 publications between 2020 and 2020, average publication date October 2020. NF-E2-Related Factor 2, 1 publications between 2021 and 2021, average publication date November 2021. Proto-Oncogene Proteins p21(ras), 1 publications between 2021 and 2021, average publication date November 2021.

To see the data from this visualization as text, click here.
Khosrowjerdi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (31)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.